Your browser is unsupported and may have security vulnerabilities! Upgrade to a newer browser to experience this site in all it's glory.
Skip to main content

From Insider Media | Thursday 20 December 2018

Device is designed to address complex meniscal tear patterns not adequately served by other repair systems.

Ceterix
The technology is "highly complementary" to Smith & Nephew's FAST-FIX 360 Meniscal Repair System.

Historic medical equipment manufacturing giant Smith & Nephew has agreed a deal to acquire the US-based developer of a new device for a fee that could rise to $105m (£82.8m).

Ceterix Orthopaedics is the company behind the NovoStitch Pro Meniscal Repair System. The device has been designed to address complex meniscal tear patterns not adequately served by other repair systems.

Smith & Nephew said the technology was "highly complementary" to its own FAST-FIX 360 Meniscal Repair System, which addresses vertical tears.

Smith & Nephew will pay an initial cash consideration of $50m and up to a further $55m over the next five years, dependant on financial performance.

Read the full story here.

Get in touch

Hull City Council, Guildhall,
Hull, East Yorkshire,
HU1 2AA,
UK

01482 300 301

Useful Information